close

MDS, Inc., a life sciences company, provides products and services for the development of drugs, and the diagnosis and treatment of diseases. It operates in three segments: MDS Pharma Services, MDS Nordion, and MDS Analytical Technologies. The MDS Pharma Services segment provides pharmaceutical research services, including pre-clinical development, and Phase IV clinical trials for generic pharmaceutical and biotechnology companies, as well as consumer product and drug delivery companies. The MDS Nordion segment offers medical isotopes for molecular imaging, technologies for the sterilization of medical and other products, and contract manufacturing services for the radio therapeutics industry. The MDS Analytical Technologies segment focuses on the research, design, manufacture, and marketing of life sciences tools, such as high-end mass spectrometers and high-performance bio-analytical measurement systems. The company serves pharmaceutical manufacturers, biotechnology companies, manufacturers of medical supplies and devices, and academic and government institutions, as well as food and environmental testing industries. It sells its products and services in the United States, Europe, Asia, Canada, and internationally. The company, formerly known as MDS Health Group Limited, was founded in 1969 and is headquartered in Mississauga, Canada.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	0.00
Volume	0
Volume Avg	224992
52 Week High	11.22
52 Week Low	7.14
PE	N/A
PE (group average)	39
EPS Year	0.00
EPS change Q/Q	-26.89%
EPS change Q/Q Yr ago	-521.43%
EPS change Q/Q next Q est	100%
EPS change Y/Y	-33.51%
REV change Q/Q	21.74%
REV change Q/Q Yr ago	-13.85%
EPS next Q est	0.00
EPS next Y est	0.00
Divident Annual	0.00
Dividend Yield	0%